Anne Clavreul
- Molecular Biology top 5%
- Genetics top 1%
- Biomaterials top 2%
- Biomedical Engineering top 5%
- Oncology top 10%
- Co-authors
- Philippe MeneïJean‐Pierre BenoîtCatherine PassiraniMarie MorilleFrédéric LagarceJean‐Michel LeméeKhaled MessaoudiClaudia N. Montero‐Menei
- Topics
- Glioma Diagnosis and Treatment (25 papers)RNA Interference and Gene Delivery (16 papers)Nanoparticle-Based Drug Delivery (9 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Anne Clavreul
61 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Molecular Biology 1.6k
- Genetics 811
- Biomaterials 673
- Biomedical Engineering 661
- Oncology 445
Countries citing papers authored by Anne Clavreul
This map shows the geographic impact of Anne Clavreul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Clavreul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Clavreul more than expected).
Fields of papers citing papers by Anne Clavreul
This network shows the impact of papers produced by Anne Clavreul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Clavreul. The network helps show where Anne Clavreul may publish in the future.
Co-authorship network of co-authors of Anne Clavreul
This figure shows the co-authorship network connecting the top 25 collaborators of Anne Clavreul. A scholar is included among the top collaborators of Anne Clavreul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Clavreul. Anne Clavreul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 6 | |
| 3 | 11 | |
| 4 | 49 | |
| 5 | 81 | |
| 6 | 15 | |
| 7 | 23 | |
| 8 | 34 | |
| 9 | 42 | |
| 10 | 28 | |
| 11 | 215 | |
| 12 | 22 | |
| 13 | 16 | |
| 14 | 43 | |
| 15 | 25 | |
| 16 | 61 | |
| 17 | 78 | |
| 18 | 116 | |
| 19 | 19 | |
| 20 | 33 |
About Anne Clavreul
Anne Clavreul is a scholar working on Genetics, Biomaterials and Pharmaceutical Science, having authored 61 papers that have together received 3.0k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (25 papers), RNA Interference and Gene Delivery (16 papers) and Nanoparticle-Based Drug Delivery (9 papers). The work is most often cited by research in Genetics (811 citations), Biomaterials (673 citations) and Pharmaceutical Science (209 citations). Anne Clavreul has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Philippe Meneï, Jean‐Pierre Benoît, Catherine Passirani, Marie Morille, Frédéric Lagarce, Jean‐Michel Lemée, Khaled Messaoudi, Claudia N. Montero‐Menei, Marie‐Claire Venier‐Julienne and Mathilde Roger. Their work appears in journals such as The Journal of Immunology, Biomaterials and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.